Hidradenitis Suppurativa
📧 Sign up to get email alerts when something new happens for Hidradenitis Suppurativa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-04Clinical Trial Update: Gentian Violet Treatment for Hidradenitis Suppurativa [Phase 2]
A Phase 2 trial evaluating Gentian Violet for hidradenitis suppurativa has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Mindfulness Training Hidradenitis Suppurativa (HS) [NA]
A University of Miami-sponsored clinical trial assessing mindfulness training for hidradenitis suppurativa (with a focus on quality of life)…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
A prospective exploratory biomarker study called SKINERGY sponsored by Leiden University Medical Center is recruiting to profile skin diseas…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Regulation of Inflammatory Genes in Hidradenitis Suppurativa
A University of Alabama at Birmingham clinical trial is investigating regulation of inflammatory genes in hidradenitis suppurativa and is cu…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
Clinical trial update shows recruitment for a study evaluating secukinumab (Cosentyx) for moderate to severe hidradenitis suppurativa. The s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: HIDRAdenitis Suppurativa and HEART Disease
This ClinicalTrials.gov entry reports an active, not-recruiting trial sponsored by Herlev and Gentofte Hospital investigating hidradenitis s…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients [Phase 1]
Phase I study of QLS12010 capsules evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects in healthy adults a…
-
FDA approval · 2025-07-29FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Sandoz Inc for the adalimumab biosimilar ADALIMUMAB-ADAZ, enabling its use with indications cons…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Determinants of Chronic Inflammatory Skin Disease Trajectories
An ongoing clinical study is investigating determinants of chronic inflammatory skin disease trajectories, spanning multiple conditions such…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Neutralizing Interferon Type 1 in Hidradenitis Suppurativa [Phase 1]
A Phase 1 clinical trial is evaluating a therapy that neutralizes type 1 interferon in hidradenitis suppurativa. The study status is not yet…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients [Phase 3]
A Phase 3 clinical trial evaluating an adapted antibiotic regimen for Hurley stage 2 hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.
This clinical trial update summarizes the impact of untreated depression and anxiety on patients with skin diseases in Jeddah, Saudi Arabia.…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin [NA]
Johns Hopkins University sponsors a feasibility study evaluating radiofrequency-based selective electrothermolysis on human skin. The trial,…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases [NA]
A completed clinical trial conducted by Universitätsklinikum Hamburg-Eppendorf evaluating an online intervention to reduce self-stigma in pe…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial [Phase 2]
This Phase 2 clinical trial update reports long-term Spesolimab treatment in people with hidradenitis suppurativa who completed a prior tria…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa. [EARLY_Phase 1]
An open-label, dose-escalation Phase 1 study is evaluating the safety and efficacy of subcutaneous siplizumab for hidradenitis suppurativa, …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
A Phase 3 trial evaluating subcutaneous sonelokimab versus placebo for moderate-to-severe hidradenitis suppurativa is currently active but n…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Phase 3 clinical trial is evaluating subcutaneous sonelokimab versus placebo for moderate to severe hidradenitis suppurativa; the study is c…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS). [Phase 2]
A Phase 2 trial evaluating deucravacitinib versus placebo for hidradenitis suppurativa has been terminated; no efficacy or safety results ar…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa [Phase 1, Phase 2]
A Phase 1/2 clinical trial to evaluate the safety, tolerability, efficacy, and pharmacokinetics of LT-002-158 tablets in Chinese adults with…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
Ongoing clinical trial evaluating the efficacy and safety of secukinumab in conjunction with surgery for moderate-to-severe hidradenitis sup…
-
FDA approval · 2025-04-07FDA Approved: ADALIMUMAB — Supplemental Application (CELLTRION USA, Inc.)
FDA approved a supplemental application for ADALIMUMAB-AATY, a biosimilar adalimumab from Celltrion USA, Inc., in connection with its regula…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating sclerotherapy for treating fistulas and sinus tracts in hidradenitis suppurativa; results have been posted…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers [Phase 1]
This Phase 1 trial update describes a single- and multiple-ascending dose study of LT-002-158 tablets in healthy adult volunteers, with recr…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Pathophysiological Basis of Hidradenitis Suppurativa
This clinical trial aims to study the pathophysiological basis of hidradenitis suppurativa. The study is currently not yet recruiting.